Biocytogen
Qiurong Wang is currently serving as the Regional Director of Business Development at Biocytogen since July 2022, having previously held roles as a Senior Business Development Manager and Business Development Manager within the same company. Prior to this, Qiurong Wang worked as a Postdoctoral Researcher at the Center for the Study of Fetal Programming at the University of Wyoming from May 2016 to June 2022, focusing on the effects of maternal over-nutrition and obesity on offspring cardiac remodeling and function. Earlier experience includes a position as a Research Assistant at the Center for Cardiovascular Research Alternative Medicine at the University of Wyoming, where Qiurong Wang engaged in research analyzing environmental toxins' effects on cardiovascular function using transgenic mouse models. Qiurong Wang holds a Doctor of Philosophy (PhD) in Computational Biology and Pharmaceuticals from the University of Wyoming, a Master of Science (M.S.) in Bioinformatics from Chalmers University of Technology, and a Bachelor of Science (B.S.) in Biotechnology from Harbin Institute of Technology.
Biocytogen
2 followers
Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for antibody drug discovery, Biocytogen offers animal model generation, antibody fully human-mouse (RenMab mouse), therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO, and regulatory affairs support.